Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Malignant Solid Tumor - Malignant Nervous System Neoplasm × cabazitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 3 Neoplasms 2 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Oligodendroglioma 1 Metastatic Castration-resistant Prostate Cancer 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Carcinoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

cabazitaxel 1 XRP6258 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01751308 2016-08-12

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Sanofi

Phase 1/2 Completed

39 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor - Malignant Nervous System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡